aTyr Pharma (LIFE) Tops Q1 EPS by 1c

aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $27.5 thousand.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• Progress Software completes $400M acquisition of Domo's data platform